T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells

被引：0
|
作者：
K Mihara
J Bhattacharyya
A Kitanaka
K Yanagihara
T Kubo
Y Takei
H Asaoku
Y Takihara
A Kimura
机构：
[1] Research Institute for Radiation Biology and Medicine,Department of Hematology and Oncology
[2] Hiroshima University,Department of Laboratory Medicine
[3] Faculty of Medicine,Department of Life Science
[4] Kagawa University,Department of Biochemistry
[5] Yasuda Women’s University Faculty of Pharmacy,Department of Clinical Laboratory
[6] Nagoya University Graduate School of Medicine,Department of Stem Cell Biology
[7] Hiroshima Red Cross Hospital & Atomic-Bomb Survivors Hospital,undefined
[8] Research Institute for Radiation Biology and Medicine,undefined
[9] Hiroshima University,undefined
来源：
Leukemia | 2012年 / 26卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：365 / 367
页数：2
相关论文
共 50 条
  • [11] Specific Targeting of Multiple Myeloma by Dual Split-signaling Chimeric Antigen Receptor T cells Directed against CD38 and CD138
    van der Schans, Jort J.
    Wang, Ziyu
    van Arkel, Jennemiek
    van Schaik, Thijs
    Katsarou, Afroditi
    Ruiter, Ruud
    Baardemans, Thomas
    Yuan, Huipin
    de Bruijn, Joost
    Zweegman, Sonja
    van de Donk, Niels W. C. J.
    Groen, Richard W. J.
    Themeli, Maria
    Mutis, Tuna
    CLINICAL CANCER RESEARCH, 2023, 29 (20) : 4219 - 4229
  • [12] CD38 as a pan-hematologic target for chimeric antigen receptor T cells
    Glisovic-Aplenc, Tina
    Diorio, Caroline
    Chukinas, John A.
    Veliz, Kimberly
    Shestova, Olga
    Shen, Feng
    Nunez-Cruz, Selene
    Vincent, Tiffaney L.
    Miao, Fei
    Milone, Michael C.
    June, Carl H.
    Teachey, David T.
    Tasian, Sarah K.
    Aplenc, Richard
    Gill, Saar
    BLOOD ADVANCES, 2023, 7 (16) : 4418 - 4430
  • [13] Deletion of CD38 enhances CD19 chimeric antigen receptor T cell function
    Veliz, Kimberly
    Shen, Feng
    Shestova, Olga
    Shestov, Maksim
    Shestov, Alexander
    Sleiman, Sara
    Hansen, Tyler
    O'Connor, Roddy S.
    Gill, Saar
    MOLECULAR THERAPY ONCOLOGY, 2024, 32 (02):
  • [14] Nicotinamide-Expanded Allogeneic Natural Killer Cells with CD38 Deletion, Expressing an Enhanced CD38 Chimeric Antigen Receptor, Target Multiple Myeloma Cells
    Edri, Avishay
    Ben-Haim, Nimrod
    Hailu, Astar
    Brycman, Nurit
    Berhani-Zipori, Orit
    Rifman, Julia
    Cohen, Sherri
    Yackoubov, Dima
    Rosenberg, Michael
    Simantov, Ronit
    Teru, Hideshima
    Kurata, Keiji
    Anderson, Kenneth Carl
    Hendel, Ayal
    Pato, Aviad
    Geffen, Yona
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (24)
  • [15] T-cell receptor delta rearrangements are present in normal cord blood CD34(+) CD38(dim) cells, not CD34(-) CD38(-) cells.
    Kerkof, KN
    Shah, AJ
    Smogorzewska, EM
    Smith, S
    Crooks, GM
    Weinberg, KI
    BLOOD, 1995, 86 (10) : 642 - 642
  • [16] Targeting CD38 and CD138 Antigens through NK Cell Immunotherapy for Effective Treatment of Multiple Myeloma
    Lee, Seung-Hwan
    Jo, Dong-Hyeon
    Kaczmarek, Shelby
    Ghaziasgar, Safa
    Shin, Oksu
    Shin, Joy
    Cowan, Juthaporn
    Mccomb, Scott
    Visram, Alissa
    JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
  • [17] Towards effective immunotherapy of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38 monoclonal antibody daratumumab
    van der Veer, Michael. S.
    de Weers, Michel
    van Kessel, Berris
    Bakker, Joost M.
    Wittebol, Shulamiet
    Parren, Paul W. H. I.
    Lokhorst, Henk M.
    Mutis, Tuna
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (02): : 284 - 290
  • [18] GDA-601: NAM-NK CELLS WITH CD38 KNOCKOUT EXPRESSES ENHANCED CD38 CHIMERIC ANTIGEN RECEPTOR AND TARGETS MULTIPLE MYELOMA CELLS WITH INCREASED CYTOTOXICITY
    Edri, A.
    Hailu, A.
    Ben Haim, N.
    Brycman, N.
    Berhani-Zipori, O.
    Rifman, J.
    Cohen, S.
    Yackoubov, D.
    Simantov, R.
    Hendel, A.
    Pato, A.
    Geffen, Y.
    CYTOTHERAPY, 2022, 24 (05) : S115 - S115
  • [19] Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma
    Garfall, Alfred L.
    Maus, Marcela V.
    Hwang, Wei-Ting
    Lacey, Simon F.
    Mahnke, Yolanda D.
    Melenhorst, J. Joseph
    Zheng, Zhaohui
    Vogl, Dan T.
    Cohen, Adam D.
    Weiss, Brendan M.
    Dengel, Karen
    Kerr, Naseem D. S.
    Bagg, Adam
    Levine, Bruce L.
    June, Carl H.
    Stadtmauer, Edward A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (11): : 1040 - 1047
  • [20] Evaluation of CD38 Expression in T-cell Lymphoproliferative Disorders
    Grant, Michelle L.
    Lunde, John H.
    Devitt, Katherine A.
    Gardner, Juli-Anne
    LABORATORY INVESTIGATION, 2017, 97 : 352A - 352A
12345